This is not a technology choice. It is the most structuring trade-off a leader can make in the AI era. It determines your dependencies, your competitive advantage and your capacity to pivot in 5 years.
Building internally is betting on scarce talent and long timelines. Buying means accepting vendor dependency on data, models and contractual terms you don't control. Partnering means sharing value and potentially visibility into your critical processes with a third party whose interests are not aligned with yours.
Most executive teams choose based on immediate cost or speed of deployment. These are the wrong criteria. The right criteria are: which dependencies does this create, and under what conditions can we exit in 3 years?
Build/buy/partner analyses systematically underestimate four elements:
The real exit cost : rarely modelled, always underestimated. In 3 years, migrating from a solution embedded in your processes costs 3 to 5x the entry price.
Model dependency : if your proprietary data has fed your vendor's model, you have funded an asset that no longer belongs to you.
Regulatory exposure : who is the operator under the EU AI Act? You or your vendor? The answer determines who bears the €30M fine.
Differentiation loss : your competitor can buy the same solution tomorrow. What you have not built, they can acquire.
A rigorous build/buy/partner analysis maps: the dependencies created by each scenario, the exit cost at 3 years, the contractual terms that lock in or preserve optionality, and the option that best preserves competitive advantage and strategic flexibility. Not a technical recommendation. A structured strategic decision.
The build/buy/partner decision in AI refers to the strategic choice by which an organisation determines whether to develop an AI capability internally (build), acquire an existing market solution (buy), or co-develop with a third party (partner). It is one of the most consequential decisions in AI-era corporate strategy because each option creates fundamentally different dependency profiles, risk distributions and competitive positions : and because the decision is largely irreversible once implemented at scale.
The build option preserves maximum strategic sovereignty: the organisation retains ownership of models, data and processes. However it requires scarce AI talent, extended development timelines and tolerance for failure risk that most mid-market and large industrial organisations cannot absorb at pace. The buy option accelerates deployment and reduces upfront investment, but creates structural dependencies: data transmitted to vendor systems may be used for model improvement under standard contract terms, model performance is subject to vendor pricing decisions, and migration costs increase over time as internal processes are redesigned around external outputs. The partner option distributes risk but introduces a third party into critical process visibility, creates potential for interest divergence over the partnership lifecycle, and may compromise competitive differentiation if the partner serves competing organisations.
Rational arbitration of the build/buy/partner decision requires evaluating four criteria simultaneously: the exit cost at 24 and 36 months for each scenario, the criticality of the data involved and its exposure under each option, the competitive differentiation delivered and whether it can be preserved under a buy or partner structure, and EU AI Act classification implications : since certain AI use cases impose compliance obligations that affect which deployment model is legally appropriate.
Once the decision is made, it is rarely reversible. The intervention window closes at the exact moment you think you still have time.
We intervene before signing to produce the complete strategic reading: dependencies created, real exit cost, EU AI Act exposure, capacity to pivot in 3 years.
let's talk